{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:52:32Z","timestamp":1780102352121,"version":"3.54.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T00:00:00Z","timestamp":1448409600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s00393-015-0009-7","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T06:37:57Z","timestamp":1448433477000},"page":"887-897","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Biomarker f\u00fcr chronisch-entz\u00fcndliche Erkrankungen","Biomarkers for chronic inflammatory diseases"],"prefix":"10.1007","volume":"74","author":[{"given":"D.","family":"Holzinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"F\u00f6ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,25]]},"reference":[{"key":"9_CR1","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","volume":"454","author":"Medzhitov","year":"2008","unstructured":"Medzhitov R (2008) Origin and physiological roles of inflammation. Nature 454:428\u2013435","journal-title":"Nature"},{"key":"9_CR2","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ni1276","volume":"6","author":"Serhan","year":"2005","unstructured":"Serhan CN, Savill J (2005) Resolution of inflammation: the beginning programs the end. Nat Immunol 6:1191\u20131197","journal-title":"Nat Immunol"},{"key":"9_CR3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1172\/JCI34431","volume":"118","author":"Barton","year":"2008","unstructured":"Barton GM (2008) A calculated response: control of inflammation by the innate immune system. J Clin Invest 118:413\u2013420","journal-title":"J Clin Invest"},{"key":"9_CR4","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/art.24298","volume":"60","author":"Knowlton","year":"2009","unstructured":"Knowlton N, Jiang K, Frank MB et al (2009) The meaning of clinical remission in polyarticular juvenile idiopathic arthritis: gene expression profiling in peripheral blood mononuclear cells identifies distinct disease states. Arthritis Rheum 60:892\u2013900","journal-title":"Arthritis Rheum"},{"key":"9_CR5","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/art.20836","volume":"51","author":"Benito-Garcia","year":"2004","unstructured":"Benito-Garcia E, Schur PH, Lahita R et al (2004) Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-Sm and anti-RNP antibody tests. Arthritis Rheum 51:1030\u20131044","journal-title":"Arthritis Rheum"},{"key":"9_CR6","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"Gabay","year":"1999","unstructured":"Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448\u2013454","journal-title":"N Engl J Med"},{"key":"9_CR7","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1473-3099(12)70323-7","volume":"13","author":"Wacker","year":"2013","unstructured":"Wacker C, Prkno A, Brunkhorst FM et al (2013) Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis 13:426\u2013435","journal-title":"Lancet Infect Dis"},{"key":"9_CR8","doi-asserted-by":"crossref","first-page":"R40","DOI":"10.1186\/ar4469","volume":"16","author":"Kay","year":"2014","unstructured":"Kay J, Morgacheva O, Messing SP et al (2014) Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year. Arthritis Res Ther 16:R40","journal-title":"Arthritis Res Ther"},{"key":"9_CR9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/acr.20052","volume":"Res","author":"Kushner","year":"2010","unstructured":"Kushner I, Samols D, Magrey M (2010) A unifying biologic explanation for \u201ehigh-sensitivity\u201c C-reactive protein and \u201elow-grade\u201c inflammation. Arthritis Care Res (Hoboken) 62:442\u2013446","journal-title":"Arthritis Care"},{"key":"9_CR10","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1136\/annrheumdis-2012-201329","volume":"71","author":"Gerss","year":"2012","unstructured":"Gerss J, Roth J, Holzinger D et al (2012) Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative study. Ann Rheum Dis 71:1991\u20131997","journal-title":"Ann Rheum Dis"},{"key":"9_CR11","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMoa070265","volume":"356","author":"Lachmann","year":"2007","unstructured":"Lachmann HJ, Goodman HJ, Gilbertson JA et al (2007) Natural history and outcome in systemic AA amyloidosis. N Engl J Med 356:2361\u20132371","journal-title":"N Engl J Med"},{"key":"9_CR12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/art.30076","volume":"63","author":"Ravelli","year":"2011","unstructured":"Ravelli A, Varnier GC, Oliveira S et al (2011) Antinuclear antibody-positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis. Arthritis Rheum 63:267\u2013275","journal-title":"Arthritis Rheum"},{"key":"9_CR13","first-page":"386","volume":"30","author":"Flato","year":"2003","unstructured":"Flato B, Lien G, Smerdel A et al (2003) Prognostic factors in juvenile rheumatoid arthritis: a case-control study revealing early predictors and outcome after 14.9 years. J Rheumatol 30:386\u2013393","journal-title":"J Rheumatol"},{"key":"9_CR14","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/08820130802438057","volume":"37","author":"Habib","year":"2008","unstructured":"Habib HM, Mosaad YM, Youssef HM (2008) Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis. Immunol Invest 37:849\u2013857","journal-title":"Immunol Invest"},{"key":"9_CR15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0272-2712(01)00012-9","volume":"22","author":"Keren","year":"2002","unstructured":"Keren DF (2002) Antinuclear antibody testing. Clin Lab Med 22:447\u2013474","journal-title":"Clin Lab Med"},{"key":"9_CR16","first-page":"S112","volume":"32","author":"Sinico","year":"2014","unstructured":"Sinico RA, Radice A (2014) Antineutrophil cytoplasmic antibodies (ANCA) testing: detection methods and clinical application. Clin Exp Rheumatol 32:S112\u2013S117","journal-title":"Clin Exp Rheumatol"},{"key":"9_CR17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/ncprheum0084","volume":"2","author":"Woo","year":"2006","unstructured":"Woo P (2006) Systemic juvenile idiopathic arthritis: diagnosis, management, and outcome. Nat Clin Pract Rheumatol 2:28\u201334","journal-title":"Nat Clin Pract Rheumatol"},{"key":"9_CR18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.clim.2012.11.008","volume":"147","author":"Kessel","year":"2013","unstructured":"Kessel C, Holzinger D, Foell D (2013) Phagocyte-derived S100 proteins in autoinflammation: putative role in pathogenesis and usefulness as biomarkers. Clin Immunol 147:229\u2013241","journal-title":"Clin Immunol"},{"key":"9_CR19","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2010.375","volume":"303","author":"Foell","year":"2010","unstructured":"Foell D, Wulffraat N, Wedderburn LR et al (2010) Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA 303:1266\u20131273","journal-title":"JAMA"},{"key":"9_CR20","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/acr.22248","volume":"Res","author":"Rothmund","year":"2014","unstructured":"Rothmund F, Gerss J, Ruperto N et al (2014) Validation of relapse risk biomarkers for routine use in patients with juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 66:949\u2013955","journal-title":"Arthritis Care"},{"key":"9_CR21","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/ard.2006.061853","volume":"66","author":"De","year":"2007","unstructured":"De Jager W, Hoppenreijs EP, Wulffraat NM et al (2007) Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. Ann Rheum Dis 66:589\u2013598","journal-title":"Ann Rheum Dis"},{"key":"9_CR22","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/ibd.21903","volume":"18","author":"Prideaux","year":"2012","unstructured":"Prideaux L, De Cruz P, Ng SC et al (2012) Serological antibodies in inflammatory bowel disease: a systematic review. Inflamm Bowel Dis 18:1340\u20131355","journal-title":"Inflamm Bowel Dis"},{"key":"9_CR23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.gtc.2012.01.001","volume":"41","author":"Sellin","year":"2012","unstructured":"Sellin JH, Shah RR (2012) The promise and pitfalls of serologic testing in inflammatory bowel disease. Gastroenterol Clin North Am 41:463\u2013482","journal-title":"Gastroenterol Clin North Am"},{"key":"9_CR24","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/ajg.2013.360","volume":"108","author":"Dabritz","year":"2013","unstructured":"Dabritz J, Bonkowski E, Chalk C et al (2013) Granulocyte macrophage colony-stimulating factor auto-antibodies and disease relapse in inflammatory bowel disease. Am J Gastroenterol 108:1901\u20131910","journal-title":"Am J Gastroenterol"},{"key":"9_CR25","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/MPG.0b013e3181fe2d93","volume":"52","author":"Nylund","year":"2011","unstructured":"Nylund CM, D\u2019mello S, Kim MO et al (2011) Granulocyte macrophage-colony-stimulating factor autoantibodies and increased intestinal permeability in Crohn disease. J Pediatr Gastroenterol Nutr 52:542\u2013548","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"9_CR26","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1080\/00365510701452838","volume":"67","author":"Peterson","year":"2007","unstructured":"Peterson CG, Sangfelt P, Wagner M et al (2007) Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis. Scan J Clin Lab Invest 67:810\u2013820","journal-title":"Scan J Clin Lab Invest"},{"key":"9_CR27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/00365520510023909","volume":"41","author":"Lettesjo","year":"2006","unstructured":"Lettesjo H, Hansson T, Peterson C et al (2006) Detection of inflammatory markers in stools from patients with irritable bowel syndrome and collagenous colitis. Scand J Gastroenterol 41:54\u201359","journal-title":"Scand J Gastroenterol"},{"key":"9_CR28","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1572-0241.2007.01126.x","volume":"102","author":"Von","year":"2007","unstructured":"Von Roon AC, Karamountzos L, Purkayastha S et al (2007) Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy. Am J Gastroenterol 102:803\u2013813","journal-title":"Am J Gastroenterol"},{"key":"9_CR29","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/MIB.0b013e318280b1cd","volume":"19","author":"Dabritz","year":"2013","unstructured":"Dabritz J, Langhorst J, Lugering A et al (2013) Improving relapse prediction in inflammatory bowel disease by neutrophil-derived S100A12. Inflamm Bowel Dis 19:1130\u20131138","journal-title":"Inflamm Bowel Dis"},{"key":"9_CR30","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1136\/gut.2006.113431","volume":"56","author":"Kaiser","year":"2007","unstructured":"Kaiser T, Langhorst J, Wittkowski H et al (2007) Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Gut 56:1706\u20131713","journal-title":"Gut"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-015-0009-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-015-0009-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-015-0009-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T12:37:28Z","timestamp":1559047048000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-015-0009-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,25]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["9"],"URL":"https:\/\/doi.org\/10.1007\/s00393-015-0009-7","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,25]]}}}